Group Eczema Education Visits:Impact on Patient and Family Quality of Life



Status:Recruiting
Conditions:Skin and Soft Tissue Infections, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:Any - 6
Updated:4/2/2016
Start Date:May 2010
Contact:Susan J. Tofte, FNP-C
Email:toftes@ohsu.edu
Phone:503 494 6445

Use our guide to learn which trials are right for you!

The objective of this study is to determine whether group educational visits improve the
quality of life of patients referred to the Dermatology Clinic. Secondary outcomes will be
to determine whether group educational visits influences other key elements of patient care
such as topical steroid usage, disease exacerbations, emergency visits, and phone calls to
the office. Lastly, the investigators hope to evaluate which aspects of the educational
visit were found to be the most helpful to families caring for children with atopic
dermatitis (AD). Patients will be new atopic dermatitis referrals to OHSU dermatology and
pediatric dermatology clinics. All consecutive patients with such appointments during a
three month time period will be screened for participation in the study. Parents will be
recruited via telephone. In the intervention group, parents will be invited to participate
in a group education visit prior to their first appointment with a dermatologist. All
parents in the study will fill out questionnaires. The children involved in the study will
be assigned an eczema severity score during their routine visits, but this will be
incorporated into the regular clinic assessment. The Childhood Atopic Dermatitis Impact
Scale (CADIS) assesses the quality of life in households with children who have atopic
dermatitis. The Eczema Area and Severity Index (EASI) measures the extent and severity of
the patient's atopic dermatitis. The change in CADIS scores will be analyzed to determine if
there is a more significant improvement in quality of life for the group in which parents
receive the group eczema education visit.


Inclusion Criteria:

- Children ages 2 months though 6 years.

- Participants must carry a diagnosis of atopic dermatitis according to the Hanifin and
Rajka criteria.

- New patients or consultations at an OHSU clinic.

- English-speaking families will be included in this study

Exclusion Criteria:

- Subjects who have been on systemic therapies for treatment of their atopic dermatitis
(prednisone or cyclosporine)
We found this trial at
1
site
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials